TrialBMC cancer2023

Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients.

Mohammad Ahmadvand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.